Clinical Trial Update: Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating aliskiren alone and in combination with enalapril for chronic heart failure; results were posted after completion to evaluate efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Aliskiren (Aliskiren)
• Aliskiren/Enalapril (aliskiren/enalapril)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2016-11-25